Yüklüyor......
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
<p>Abstract</p> <p>Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically selected BRCA1-carriers for the neoadjuvant treatment and used monotherapy by cisplatin instead of conventional schemes. Although the TNM staging of the recruited patients...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2009-04-01
|
| Seri Bilgileri: | Hereditary Cancer in Clinical Practice |
| Online Erişim: | http://www.hccpjournal.com/content/7/1/8 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|